David E. Lazar - Jan 24, 2023 Form 4 Insider Report for TITAN PHARMACEUTICALS INC (TTNP)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ David E. Lazar
Stock symbol
TTNP
Transactions as of
Jan 24, 2023
Transactions value $
$56,287
Form type
4
Date filed
1/26/2023, 12:05 PM
Previous filing
Jul 8, 2022
Next filing
Jun 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTNP Common Stock, par value $0.001 Purchase $36.2K +37.5K +1.13% $0.97 3.37M Jan 24, 2023 Direct F1, F2, F3
transaction TTNP Common Stock, par value $0.001 Purchase $20.1K +20K +0.59% $1.00 3.39M Jan 25, 2023 Direct F2, F3, F4
holding TTNP Common Stock, par value $0.001 359K Jan 24, 2023 By Activist Investing LLC F2, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $0.9591 to $0.98. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.
F2 This Form 4 is filed jointly by Activist Investing LLC ("Activist Investing") and David E. Lazar (collectively, the "Reporting Persons").
F3 Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
F4 Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $0.97 to $1.01. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.
F5 Securities of the Issuer beneficially owned directly by Activist Investing. Mr. Lazar, as the sole member and Chief Executive Officer of Activist Investing, may be deemed the beneficial owner of the securities of the Issuer beneficially owned by Activist Investing.